Fast Retailing, J. Front, Kaken, Nissan, OSG, Sawai Pharma: Equity Preview
The following companies may have unusual price changes in Japanese trading today. Stock symbols are in parentheses, and share prices are as of the latest close. The information in each item was released after markets shut, unless stated otherwise.
Canon Inc. (7751 JT): The world’s largest maker of cameras and office equipment filed patent-infringement claims against China’s Ninestar Image International Ltd. and retailers over technology in printer toner cartridges. The stock dropped 2.7 percent to 3,395 yen.
Chuo Mitsui Trust & Banking Co. (8309 JT): The lender said it aims to sell 200 billion yen in ($2.2 billion) in Japanese stock-based investments to overseas pension funds this year as it targets growth abroad. The stock retreated 3 percent to 320 yen.
Fast Retailing Co. (9983 JT): The apparel retailer said it formed a venture with Malaysia’s DNP Clothing Sdn. to operate Uniqlo stores in the southeast Asian nation. Fast Retailing declined 1 percent to 13,980 yen.
Heiwado Co. (8276 JT): The supermarket chain said first- quarter net income jumped to 1.17 billion yen from 804 million yen a year earlier, while sales fell 4.7 percent to 90.6 billion yen. The stock fell 1 percent to 1,103 yen.
J. Front Retailing Co. (3086 JT): The clothing retailer said first-quarter net income rose 7.7 percent to 1.88 billion yen from a year earlier. The stock retreated 0.2 percent to 457 yen.
JFE Holdings Inc. (5411 JT): Japan’s second-largest steelmaker may take a further six months to decide on purchasing a stake in JSW Steel Ltd., according to Sajjan Jindal, vice chairman of JSW. JFE slid 1.1 percent to 2,838 yen.
Kaken Pharmaceutical Co. (4521 JT): The Japanese drugmaker said it plans to buy back up to 4.7 percent of its outstanding shares for as much as 4.5 billion yen. The stock declined 0.9 percent to 846 yen.
Kokuyo Co. (7984 JT): The stationary maker raised its full- year net income forecast to 800 million yen from 300 million yen, while cutting the revenue forecast by 3 percent to 262 billion yen. The stock declined 2.4 percent to 747 yen.
Konica Minolta Holdings Inc. (4902 JT): The maker of film used in liquid-crystal displays may report a consolidated operating profit of about 11 billion yen for the April-to-June quarter, Nikkei English News reported. The stock sank 4 percent to 889 yen.
Mitsui & Co. (8031 JT): The trading house had its credit outlook cut to “negative” from “stable” by Standard & Poor’s Ratings Services on concern it may be affected by the oil spill in the Gulf of Mexico. The stock fell 3.2 percent to 1,075 yen.
Mochida Pharmaceutical Co. (4534 JT): The drugmaker said it will buy back as much as 0.7 percent of its outstanding stock for as much as 750 million yen. The stock slid 0.5 percent to 840 yen.
Nissan Motor Co. (7201 JT): Japan’s third-largest automaker plans to invest more than $20 million to boost its production in Indonesia, said Chief Executive Officer Carlos Ghosn. The stock retreated 1.9 percent to 629 yen.
OSG Corp. (6136 JT): The machine-tool maker said half-year net income returned to 1.32 billion yen from a 1.3 billion yen net loss a year earlier. The stock slid 1.3 percent to 976 yen.
Sawai Pharmaceutical Co. (4555 JT): Japan’s second-largest generic-drug maker is open to tie-ups with domestic and overseas pharmaceutical companies, Chairman Hiroyuki Sawai said at a briefing in Tokyo. The stock declined 3.1 percent to 8,410 yen.
Shicoh Co. (6667 JT): The Japanese maker of fan motors plans to raise 740.4 million yen by selling 4,500 shares to the public, according to a filing with the nation’s Finance Ministry. The stock rose 2.6 percent to 137,500 yen.
Sumitomo Mitsui Financial Group Inc. (8316 JT): The lender’s Sumitomo Mitsui Banking Corp. plans to invest almost 30 billion yen in Kotak Mahindra Bank, India’s fourth-largest private-sector lender, Nikkei English News reported. The stock retreated 1.3 percent to 2,575 yen.
Takeda Pharmaceutical Co. (4502 JT): The drugmaker won’t conduct share repurchases again this fiscal year as it uses cash reserves on new-drug development and acquisitions, Nikkei English News reported, citing President Yasuchika Hasegawa. The stock gained 0.1 percent to 3,875 yen.